110 Followers on Owler
Apeiron is an Austria-based biotechnology company that researches and develops antibody-based immunotherapies for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights
Apeiron is an Austria-based biotechnology company that researches and develops antibody-based immunotherapies for the treatment of cancer... Read more
Apeiron Biologics CEO: Peter Llewellyn-Davies

CEO

Peter Llewellyn-Davies

CEO Approval Rating

90/100

2003

PrivateAcquisition Pending from Ligand Pharmaceuticals Incorporated

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$49.4M

News

Acquisition
Jul 08, 2024
Business Wire
Apeiron Biologics AG Was acquired by Ligand Pharmaceuticals Incorporated for $100M

Apeiron Biologics Competitors

1OncoQR ML
2Immatics
3F-star
4Adaptimmune
5Medigene
6Montis Biosciences
7Cristal Therapeutics
8NexImmune
9Aura
10Jounce
Unlock 15 + competitors

Trending Companies